59MO Final analysis of AK105-302: A randomized, double-blind, placebo-controlled, phase III trial of penpulimab plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC

Authors:
  • BHB. Han
    B. Han
  • SJS. Jiao
    S. Jiao
  • JCJ. Chen
    J. Chen
  • ZWZ. Wang
    Z. Wang
  • YZY. Zhao
    Y. Zhao
  • GZG. Zhang
    G. Zhang
  • GCG. Chen
    G. Chen
  • MZM. Zhou
    M. Zhou
  • JZJ. Zhou
    J. Zhou
  • YDY. Du
    Y. Du
  • LWL. Wu
    L. Wu
  • ZXZ. Xu
    Z. Xu

Abstract
No abstract available